Professor Ezio Bonifacio, PhD
Center for Regenerative Therapies Dresden
Technische Universität Dresden
Dr Bonifacio was born and trained in Perth Australia. He moved to London as a post-doctoral scientist to work of type 1 diabetes prediction, and subsequently moved to Milan where he studied the autoimmune response to beta cell antigens in settings that include pre-clinical type 1 diabetes and islet transplantation. He has been instrumental in developing and standardizing tools to measure autoimmunity against beta cells and in their application to understand prediction, pathogenesis, and prevention of type 1 diabetes in children. He leads the primary insulin vaccination trial Pre-POINT.
Abstracts this author is presenting: